1. Home
  2. XRTX vs AEMD Comparison

XRTX vs AEMD Comparison

Compare XRTX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • AEMD
  • Stock Information
  • Founded
  • XRTX 2011
  • AEMD 1984
  • Country
  • XRTX Canada
  • AEMD United States
  • Employees
  • XRTX N/A
  • AEMD N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • AEMD Medical/Dental Instruments
  • Sector
  • XRTX Health Care
  • AEMD Health Care
  • Exchange
  • XRTX Nasdaq
  • AEMD Nasdaq
  • Market Cap
  • XRTX 4.2M
  • AEMD 4.1M
  • IPO Year
  • XRTX N/A
  • AEMD N/A
  • Fundamental
  • Price
  • XRTX $0.84
  • AEMD $1.22
  • Analyst Decision
  • XRTX
  • AEMD Strong Buy
  • Analyst Count
  • XRTX 0
  • AEMD 1
  • Target Price
  • XRTX N/A
  • AEMD $56.00
  • AVG Volume (30 Days)
  • XRTX 30.3K
  • AEMD 265.2K
  • Earning Date
  • XRTX 08-13-2025
  • AEMD 06-26-2025
  • Dividend Yield
  • XRTX N/A
  • AEMD N/A
  • EPS Growth
  • XRTX N/A
  • AEMD N/A
  • EPS
  • XRTX N/A
  • AEMD N/A
  • Revenue
  • XRTX N/A
  • AEMD N/A
  • Revenue This Year
  • XRTX N/A
  • AEMD N/A
  • Revenue Next Year
  • XRTX N/A
  • AEMD N/A
  • P/E Ratio
  • XRTX N/A
  • AEMD N/A
  • Revenue Growth
  • XRTX N/A
  • AEMD N/A
  • 52 Week Low
  • XRTX $0.80
  • AEMD $1.20
  • 52 Week High
  • XRTX $2.98
  • AEMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 39.98
  • AEMD 41.34
  • Support Level
  • XRTX $0.80
  • AEMD $1.40
  • Resistance Level
  • XRTX $0.88
  • AEMD $2.88
  • Average True Range (ATR)
  • XRTX 0.05
  • AEMD 0.26
  • MACD
  • XRTX -0.00
  • AEMD -0.02
  • Stochastic Oscillator
  • XRTX 24.20
  • AEMD 36.49

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: